positive tests will have colorectal neoplasia, including 5-10 per cent with cancer". Improvements in specificity using vegetable peroxidase inhibitors, faecal porphyrin assays, or immunochemical tests for blood should be possible. None of these tests will discriminate between bleeding from neoplasti
Fecal occult blood screening for colorectal cancer in the general population results of a controlled trial
β Scribed by J. D. Hardcastle; N. C. Armitage; J. Chamberlain; S. S. Amar; P. D. James; T. W. Balfour
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 614 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
All inhabitants of the city of Goteborg who in 1982 were between 60 and 64 years of age (27,700) were randomly divided into a test and a control group. The 13,759 subjects in the test group were invited to perform Hemoccult I1 (Smith Kline Diagnostic, Sunnyvale, CA) fecal occult blood testing over 3
## Abstract Colorectal cancer screening is a high public health priority in all industrialized countries. However, the low sensitivity of the common guaiac screening test (HemoccultII) makes practitioners and public health decision makers reluctant to set up a national screening program. In recent
Our controlled trial of screening for colorectal cancer has now been in progress for almost five years. Screening is accomplished by rigid sigmoidoscopy in control and study groups and, in addition, by fecal occult blood testing in the study group. Patients screened are men and women age 40 and olde